Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kari K Eklund

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Immunological Reviews|May 15, 2007
Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapyKari K Eklund
Pediatric Research|August 22, 2019
Insights image for Forskolin attenuates the NLRP3 inflammasome activation and IL-1β secretion in human macrophagesYan Chen, Kari K Eklund
Annals of Medicine|September 4, 2003
Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory casesKari K Eklund, Heikki Joensuu
Duodecim; Laaketieteellinen Aikakauskirja|October 15, 2011
[Large-vessel vasculitides]Kari K Eklund, Tom Pettersson
Duodecim; Laaketieteellinen Aikakauskirja|March 29, 2016
[Role of cytokines and their blocking in immune-mediated inflammatory diseases]Sampsa Matikainen, Sakari Jokiranta, Kari K Eklund
Biology|April 3, 2020
Osteoarthritis and Toll-Like Receptors: When Innate Immunity Meets Chondrocyte ApoptosisGoncalo Barreto, Mikko Manninen, Kari K Eklund
Acta Dermato-Venereologica|November 9, 2010
Leg ulcers treated with topical tacrolimus in patients with rheumatoid arthritisJohanna Mandelin, Kari K Eklund, Sakari Reitamo
Critical Reviews in Immunology|December 15, 2012
Immune functions of serum amyloid AKari K Eklund, K Niemi, P T Kovanen
Arthritis and Rheumatism|August 12, 2011
Is the "lipid paradox" in rheumatoid arthritis really a paradox? Comment on the article by Bartels et alTimo E Strandberg, Petri T Kovanen, Kari K Eklund
Anticancer Research|May 31, 2024
<i>Ex Vivo</i> Evaluation of Antiangiogenic Drugs in Oral Cancer: Potential Implications for Targeting Vasculogenic MimicryRoosa Hujanen, Tuula Salo, Kari K Eklund, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Immunological Reviews|May 15, 2007
Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapyKari K Eklund
Pediatric Research|August 22, 2019
Insights image for Forskolin attenuates the NLRP3 inflammasome activation and IL-1β secretion in human macrophagesYan Chen, Kari K Eklund
Annals of Medicine|September 4, 2003
Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory casesKari K Eklund, Heikki Joensuu
Duodecim; Laaketieteellinen Aikakauskirja|October 15, 2011
[Large-vessel vasculitides]Kari K Eklund, Tom Pettersson
Duodecim; Laaketieteellinen Aikakauskirja|March 29, 2016
[Role of cytokines and their blocking in immune-mediated inflammatory diseases]Sampsa Matikainen, Sakari Jokiranta, Kari K Eklund
Biology|April 3, 2020
Osteoarthritis and Toll-Like Receptors: When Innate Immunity Meets Chondrocyte ApoptosisGoncalo Barreto, Mikko Manninen, Kari K Eklund
Acta Dermato-Venereologica|November 9, 2010
Leg ulcers treated with topical tacrolimus in patients with rheumatoid arthritisJohanna Mandelin, Kari K Eklund, Sakari Reitamo
Critical Reviews in Immunology|December 15, 2012
Immune functions of serum amyloid AKari K Eklund, K Niemi, P T Kovanen
Arthritis and Rheumatism|August 12, 2011
Is the "lipid paradox" in rheumatoid arthritis really a paradox? Comment on the article by Bartels et alTimo E Strandberg, Petri T Kovanen, Kari K Eklund
Anticancer Research|May 31, 2024
<i>Ex Vivo</i> Evaluation of Antiangiogenic Drugs in Oral Cancer: Potential Implications for Targeting Vasculogenic MimicryRoosa Hujanen, Tuula Salo, Kari K Eklund, et al.
Pageof 10